CRISPR Therapeutics AG
CRISPR Therapeutics AG (CRSP) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 902 transactions totaling $514.3M, demonstrating a bearish sentiment with -$311.9M in net insider flow. The most recent transaction on Feb 19, 2026 involved a sale of 2,112 shares valued at $111.0K.
CRSP Insider Activity Summary
Who Is Buying CRSP Stock?
No significant insider buying has been recorded for CRSP in the recent period.
Who Is Selling CRSP Stock?
No significant insider selling has been recorded for CRSP in the recent period.
Is CRISPR Therapeutics AG Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CRSP is bearish with an Insider Alignment Score of 20/100 and a net flow of -$311.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CRSP Frequently Asked Questions
Understanding CRSP Insider Activity
Insider trading at CRISPR Therapeutics AG (CRSP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading CRSP stock, having executed 902 transactions in the past 90 days. The most active insider is Bradley J. Bolzon Phd (Executive), who has made 233 transactions totaling $130.0M.
Related Tools
Track CRISPR Therapeutics AG Insider Activity
Get notified when executives and directors at CRSP file new Form 4 transactions